| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Brace | Fintech Lending | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Brain Corp | Industrial Robotics | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $147.48M | Series D NV | 4/27/2020 | $27.5M | $464.23M | $5.28 | ClearBridge Advisors, Qualcomm Ventures, Satwik Ventures, SoftBank | ||||
 | Branch International | Fintech Digital Banking | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Branch Metrics | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $106.16K | -- | 1 | Not available | -- | -- | $1.88B | Series F | 2/10/2022 | $300M | $4.01B | $48.96 | New Enterprise Associates | ||||
 | Cagent Vascular | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $110.64M | Series D | 5/19/2026 | $41M | $166.6M | $0.28 | Astoria Health Investors, U.S. Venture Partners, BF Belmont, Trinity Capital | ||||
 | Calibrate | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $97.15M | Series B | 8/25/2021 | $76.9M | $382.73M | $5.35 | Founders Fund, Tiger Global Management, Optum Ventures, Threshold Ventures, Forerunner Ventures, Redesign Health | ||||
 | Calyxo | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $155.79M | Series F | 4/14/2026 | $40.1M | $658.2M | $8.82 | Ally Bridge Group, Janus Henderson Investors, Questa Capital, Avidity Partners, CRG | ||||
 | Cambridge Mobile Telematics | Fintech Insurance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $591.14M | Series B | 12/19/2018 | $505M | $1.53B | $6.21 | SoftBank | ||||
 | Capitolis | Fintech Capital Markets | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $355.35M | Series D | 8/6/2025 | $93M | $1.6B | $5.46 | Canapi Ventures, 9Yards Capital, SVB Capital, Andreessen Horowitz, Index Ventures, Sequoia Capital, S Capital, Spark Capital, Citi, State Street, J.P. Morgan, Morgan Stanley, UBS, Barclays, BNP Paribas | ||||
 | Capstan Therapeutics | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $845M | Series B | 3/20/2024 | $175M | $525.33M | $3.37 | RA Capital Management, Forbion, Johnson & Johnson, Mubadala Capital, Perceptive Advisors, Sofinnova Investments, Alexandria Venture Investments, Bristol Myers Squibb, Eli Lilly, Bayer, Novartis Venture Fund, OrbiMed, Pfizer Ventures, Polaris Partners, Vida Ventures | ||||
 | Captions | Consumer & Lifestyle Media | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Cardurion Pharma | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $866.77M | Series B | 7/16/2024 | $260.41M | $754.94M | $4.90 | Ascenta Capital, NEA, GV, Fidelity Management & Research Company, Millennium Management, Farallon Capital Management, Invus, Blue Owl Healthcare Opportunities, Delos Capital, Digitalis Ventures, Bain Capital Life Sciences, Bain Capital Private Equity. | ||||
 | CareBridge Health | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $190.85M | Series C | 6/8/2022 | $140M | $1.15B | $48.24 | Oak HC/FT, Optum Ventures, CVS Ventures, Anthem, HLM Venture Partners | ||||
 | Cast AI | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $178.43M | Series C-2 | 1/12/2026 | $5M | $1.02B | $79.71 | Pacific Alliance Ventures | ||||
 | Cellibre | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Censys | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $146.72M | Series D | 3/31/2026 | $40M | $442.95M | $3.34 | Morgan Stanley, Decibel Partners, Greylock, GV, Intel Capital, LDV Partners | ||||
 | Cerapedics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $163.58M | Series G | 6/5/2024 | $15.23M | $744.31M | $5.64 | Undisclosed Investors | ||||
 | Chili Piper | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $51.16M | Series B | 4/15/2021 | $33.16M | $347.07M | $7.39 | Tiger Global Management, Base10 Partners, Gradient Ventures | ||||
 | Chipper Cash | Fintech Payments | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $125.79K | -- | 1 | Not available | -- | -- | $301.9M | Series C-1 | 11/1/2021 | $80M | $2.23B | $38.08 | FTX, SVB Capital, Deciens Capital, Ribbit Capital, Bezos Expeditions, One Way Ventures, Tribe Capital | ||||
 | Chroma Medicine | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $262M | Series B | 3/1/2023 | $135M | $450.56M | $2.60 | ARCH Venture Partners, DCVC Bio, Mubadala Capital, Sixth Street, Alexandria Venture Investments, Atlas Venture, Casdin Vapital, Cormorant Asset Management, Janus Henderson Investors, Newpath Partners, Omega Funds, Osage University Partners, Sofinnova Partners, T Rowe Price, Wellington Management | ||||
 | Class Technologies | Education Education Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $492.13M | Series D | 3/31/2023 | $7M | $1B | $14.62 | Undisclosed Investors | ||||
 | ClassPass | Consumer & Lifestyle Fitness | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $546.72M | Series E | 1/8/2020 | $285M | $1.05B | $12.58 | Apax Partners, L Catterton, Temasek Holdings | ||||
 | Clearspeed | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $110M | Series D-2 | 6/26/2025 | $30M | $316.73M | $1.42 | Align Private Capital, IronGate Capital Advisors, Bravo Victor Venture Capital, KBW Ventures, David Petraeus | ||||
 | Cleo | Fintech Personal Finance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $10.4M | -- | 1 | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||